- Home
- JBHT vs GH Comparison
JBHT vs GH Comparison
Compare JBHT & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JBHT | GH |
|---|---|---|
| Founded | 1961 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2B | 17.3B |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | JBHT | GH |
|---|---|---|
| Price | $268.70 | $136.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 19 |
| Target Price | ★ $220.80 | $119.79 |
| AVG Volume (30 Days) | 892.6K | ★ 2.2M |
| Earning Date | 04-15-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.73% | N/A |
| EPS Growth | ★ 10.07 | 6.74 |
| EPS | ★ 1.49 | N/A |
| Revenue | ★ $7,189,568,000.00 | $982,021,000.00 |
| Revenue This Year | $5.76 | $33.30 |
| Revenue Next Year | $6.62 | $28.27 |
| P/E Ratio | $180.70 | ★ N/A |
| Revenue Growth | 9.67 | ★ 32.88 |
| 52 Week Low | $130.13 | $40.36 |
| 52 Week High | $293.54 | $135.00 |
Technical Indicators
Market Signals| Indicator | JBHT | GH |
|---|---|---|
| Relative Strength Index (RSI) | 47.58 | 67.61 |
| Support Level | $195.69 | $97.16 |
| Resistance Level | $293.54 | N/A |
| Average True Range (ATR) | 9.57 | 6.49 |
| MACD | -3.21 | -0.86 |
| Stochastic Oscillator | 9.89 | 74.77 |
Price Performance
Historical ComparisonAbout JBHT J.B. Hunt Transport Services Inc.
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (48% of sales), dedicated trucking services that provide customer-specific fleet needs (27%), for-hire truckload (6%), heavy goods final-mile delivery (7%), and asset-light truck brokerage (12%).
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.